Equities

Bristol-Myers Squibb Co

0R1F:LSE

Bristol-Myers Squibb Co

  • Price (USD)60.60
  • Today's Change2.20 / 3.77%
  • Shares traded12.72k
  • 1 Year change5.36%
  • Beta0.2814
Data delayed at least 20 minutes, as of Feb 06 2026 19:14 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Bristol-Myers Squibb Co had relatively flat revenues (48.30bn to 48.19bn), though the company grew net income from a loss of 8.95bn to a gain of 7.05bn. A reduction in the selling, general and administrative costs as a percentage of sales from 16.55% to 14.83% was a component in the net income growth despite flat revenues.
Gross margin72.62%
Net profit margin14.64%
Operating margin21.51%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2024, cash reserves at Bristol-Myers Squibb Co fell by 1.17bn. However, the company earned 15.19bn from its operations for a Cash Flow Margin of 31.45%. In addition the company generated 5.13bn cash from financing while 21.35bn was spent on investing.
Cash flow per share5.35
Price/Cash flow per share11.56
Book value per share--
Tangible book value per share--
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.81%
Div growth rate (5 year)0.66%
Payout ratio (TTM)53.67%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		178.11
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.